Ganz, Tomas
Nemeth, Elizabeta
Article History
First Online: 10 July 2015
Competing interests
: T.G and E.N. are consultants and shareholders for Merganser Biotech, a company involved in the development of minihepcidins as therapeutics. T.G. and E.N. are consultants and shareholders of Silarus Therapeutics, a company involved in the development of erythroferrone agonists and antagonists for therapeutic use.